FY2018 Earnings Estimate for Molina Healthcare, Inc. Issued By SunTrust Banks (MOH)

Molina Healthcare, Inc. (NYSE:MOH) – Stock analysts at SunTrust Banks boosted their FY2018 earnings per share (EPS) estimates for shares of Molina Healthcare in a research report issued on Tuesday, November 6th. SunTrust Banks analyst D. Macdonald now forecasts that the company will post earnings of $8.11 per share for the year, up from their previous forecast of $6.69. SunTrust Banks currently has a “Buy” rating and a $140.00 price target on the stock. SunTrust Banks also issued estimates for Molina Healthcare’s Q1 2019 earnings at $2.36 EPS, Q2 2019 earnings at $2.65 EPS, Q3 2019 earnings at $2.28 EPS, Q4 2019 earnings at $1.62 EPS and FY2019 earnings at $8.92 EPS.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, October 31st. The company reported $2.55 earnings per share for the quarter, beating the consensus estimate of $1.65 by $0.90. The business had revenue of $4.70 billion during the quarter, compared to analysts’ expectations of $4.72 billion. Molina Healthcare had a return on equity of 30.50% and a net margin of 1.27%. The firm’s revenue for the quarter was down 6.6% compared to the same quarter last year. During the same quarter last year, the business posted ($1.62) EPS.

MOH has been the subject of several other research reports. Bank of America raised their price target on Molina Healthcare from $94.00 to $110.00 and gave the company an “underperform” rating in a report on Wednesday, August 1st. Jefferies Financial Group cut Molina Healthcare from a “buy” rating to a “hold” rating and set a $152.00 price target for the company. in a report on Friday, October 12th. They noted that the move was a valuation call. ValuEngine cut Molina Healthcare from a “buy” rating to a “hold” rating in a report on Thursday, November 1st. Wells Fargo & Co raised their price target on Molina Healthcare from $92.00 to $120.00 and gave the company a “market perform” rating in a report on Thursday, August 2nd. Finally, Morgan Stanley raised their price target on Molina Healthcare from $108.00 to $132.00 and gave the company an “overweight” rating in a report on Thursday, August 2nd. One analyst has rated the stock with a sell rating, nine have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $130.62.

NYSE MOH opened at $134.16 on Friday. The company has a market cap of $8.57 billion, a price-to-earnings ratio of 239.57, a PEG ratio of 1.37 and a beta of 1.52. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.40 and a quick ratio of 1.40. Molina Healthcare has a 1-year low of $71.07 and a 1-year high of $154.06.

In other news, Director Dale B. Wolf sold 4,000 shares of the firm’s stock in a transaction that occurred on Friday, November 9th. The stock was sold at an average price of $135.57, for a total value of $542,280.00. Following the completion of the sale, the director now directly owns 10,214 shares of the company’s stock, valued at approximately $1,384,711.98. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider James Woys acquired 25,000 shares of the stock in a transaction dated Wednesday, September 19th. The stock was bought at an average cost of $148.79 per share, with a total value of $3,719,750.00. Following the completion of the purchase, the insider now directly owns 17,203 shares in the company, valued at $2,559,634.37. The disclosure for this purchase can be found here. Insiders sold a total of 9,016 shares of company stock valued at $1,235,805 over the last ninety days. Corporate insiders own 0.65% of the company’s stock.

Several hedge funds have recently modified their holdings of MOH. Advisors Asset Management Inc. lifted its stake in shares of Molina Healthcare by 2,264.2% during the 2nd quarter. Advisors Asset Management Inc. now owns 93,813 shares of the company’s stock worth $118,000 after acquiring an additional 89,845 shares during the last quarter. Integrated Investment Consultants LLC bought a new stake in shares of Molina Healthcare during the 2nd quarter worth approximately $165,000. Contravisory Investment Management Inc. bought a new stake in shares of Molina Healthcare during the 2nd quarter worth approximately $166,000. DekaBank Deutsche Girozentrale lifted its stake in shares of Molina Healthcare by 185.1% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 1,226 shares of the company’s stock worth $170,000 after acquiring an additional 796 shares during the last quarter. Finally, Alpha Cubed Investments LLC bought a new stake in shares of Molina Healthcare during the 3rd quarter worth approximately $200,000.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Further Reading: Calculate Your Return on Investment (ROI)

Earnings History and Estimates for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply